Healthpartners Institute

This study is testing a web-based decision support tool in primary care clinics. The tool provides personalized information to doctors and patients about the potential benefits and risks of different weight loss treatments, like medication or surgery, for people with type 2 diabe…

This small study is testing whether a non-invasive brain stimulation technique called theta burst stimulation can help improve thinking skills in people with early Alzheimer's disease. Researchers will compare the real stimulation treatment to a sham (fake) procedure in 6 partici…

This study compares two common ways people with type 2 diabetes check their blood sugar: continuous glucose monitors (CGM) worn on the skin versus traditional fingerstick tests. It involves 360 patients across 50 primary care clinics over 12 months to see which method works bette…

This study aims to better understand and manage high blood sugar, a common side effect of the breast cancer drug alpelisib. Fifteen patients with metastatic breast cancer will wear a continuous glucose monitor (CGM) for at least three months while taking the drug. The goal is to …

This study aimed to see if using a continuous glucose monitor (CGM) could help safely manage patients hospitalized for severe diabetes complications like diabetic ketoacidosis (DKA). The goal was to test the CGM alongside a new, simpler insulin injection method to reduce frequent…

This study aims to see if a newer, simpler imaging test works as well as the current standard for diagnosing severe frostbite. Researchers will compare two methods—conventional angiography and ICG microangiography—in 8 adult patients with severe frostbite. The goal is to determin…

This study aimed to measure whether insulin, when given as a nasal spray, can reach the brain and spinal cord fluid. Researchers planned to give healthy middle-aged adults either a low or high dose of insulin nasal spray or a placebo, then collect spinal fluid samples to measure …

This study aims to create a registry to understand how the recently approved Alzheimer's drug lecanemab affects patients and their caregivers in everyday life. Researchers will enroll 20 Alzheimer's patients receiving lecanemab infusions and their caregivers to collect data on th…